Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Guofeng Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1609-581X; OpenAlex author ID A5101677613. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 6

  1. CT Findings of Undifferentiated Pancreatic Cancer With Osteoclast-Like Giant Cells: A Case Series from a Single Center's Experience With 10 Cases. Last author DOI 10.7759/cureus.43798↗
  2. Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70. Co-author DOI 10.1177/1758835920953728↗
  3. Lactic dehydrogenase to albumin ratio in prediction of unresectable pancreatic cancer with intervention chemotherapy. Co-author DOI 10.2217/fon-2017-0556↗
  4. Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer. Co-author DOI 10.7150/jca.23989↗
  5. Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up c… Co-author DOI 10.2147/ott.s116136↗
  6. Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1097/md.0000000000003098↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhihong Lan · 1 shared paper, 2023 · strength 0.26
  2. Xiangrong Yu · 1 shared paper, 2023 · strength 0.26
  3. Xiaoyu Liu · 3 shared papers, 2016–2018 · strength 0.21
  4. Shanshan Gao · 2 shared papers, 2018–2020 · strength 0.17
  5. Yi Chen · 2 shared papers, 2018–2020 · strength 0.17
  6. Xiaolin Wang · 2 shared papers, 2017–2020 · strength 0.16
  7. Xiaolin Wang · 2 shared papers, 2018 · strength 0.15
  8. Wenhui Lou · 2 shared papers, 2018 · strength 0.15
  9. Junhao Li · 2 shared papers, 2018 · strength 0.15
  10. Wenhui Lou · 1 shared paper, 2020 · strength 0.09
  11. Ning Pu · 1 shared paper, 2020 · strength 0.09
  12. Minjie Yang · 1 shared paper, 2020 · strength 0.09
  13. Hanlin Yin · 1 shared paper, 2020 · strength 0.09
  14. Qiangda Chen · 1 shared paper, 2020 · strength 0.09
  15. Jun Yu · 1 shared paper, 2020 · strength 0.09
  16. Yi Chen · 1 shared paper, 2018 · strength 0.08
  17. Tianzhu Yu · 1 shared paper, 2018 · strength 0.08
  18. Changyu Li · 1 shared paper, 2016 · strength 0.07
  19. Xiaolin Wang · 1 shared paper, 2016 · strength 0.07
  20. Dayong Jin · 1 shared paper, 2017 · strength 0.07
  21. Deliang Fu · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.